Evidence map›Paper›PMID 32785780›Full record

ArticleArchives of gynecology and obstetrics2020

Altered VEGF, Bcl-2 and IDH1 expression in patients with adenomyosis.

Cem Yalaza, Necmiye Canacankatan, İclal Gürses, Hakan Aytan, Bahar Taşdelen

Abstract read
PubMed Publisher
In one paragraph

Article in Archives of gynecology and obstetrics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 19 citations in OpenAlex.

  1. Divergent Associations of the VEGF (Medicina (Kaunas, Lithuania) · 2026
    Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. A clinical scoring system for the diagnosis of adenomyosis.Turkish journal of obstetrics and gynecology · 2022
    Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Cem YalazaDepartment of Medical Services and Techniques, Vocational School, Toros University, Mersin, Turkey. cemyalaza@gmail.com.ORCID http://orcid.org/0000-0002-9073-5611
Necmiye CanacankatanDepartment of Biochemistry, Faculty of Pharmacy, Mersin University, Mersin, Turkey.
İclal GürsesDepartment of Pathology, Cerrahpaşa Faculty of Medicine, Istanbul University, Istanbul, Turkey.
Hakan AytanDepartment of Obstetrics and Gynecology, Faculty of Medicine, Mersin University, Mersin, Turkey.
Bahar TaşdelenDepartment of Biostatistics, Faculty of Medicine, Mersin University, Mersin, Turkey.
Mersin Üniversitesi · TRIstanbul University · TRToros University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeAdenomyosis is a benign uterine disease resulting from the myometrial invasion of the endometrial gland and stroma. In the current study, angiogenesis, apoptosis and energy metabolism were investigated in adenomyosis.

methodsA retrospective study was performed using paraffin archival tissues. Three groups were included in the study: Group I and Group II; ectopic and eutopic endometrial tissues of patients with adenomyosis, respectively, and Control Group; endometrial tissue of individuals without adenomyosis. Vascular endothelial growth factor (VEGF), epidermal growth factor (EGF), intercellular adhesion molecule 1 (ICAM-1) and hypoxia-inducible factor 1 alpha (HIF-1A) levels were evaluated as angiogenic markers. Bcl-2, caspase-9 and caspase-3 levels were investigated as apoptotic indicators, and isocitrate dehydrogenase 1 (IDH1), succinate dehydrogenase complex subunit C (SDHC) and fumarate hydratase (FH) levels were also examined as energy metabolism markers. Gene expression levels of all parameters were determined by RT-PCR.

resultVEGF expression levels were found to be increased in Group I according to the control group and Group II. Bcl-2 expression levels were found to be increased in the Group I compared to the Group II. It was determined that expression levels of IDH1 were decreased in the Group I and Group II compared to the Control Group. There was no significant difference in the other examined parameters. Although we did not find a significant difference in HIF-1A levels between the groups, we found a positive correlation between VEGF and HIF-1A in the Group I.

conclusionThese results point out that VEGF, HIF-1A, Bcl-2 and IDH1 may be associated with the etiology of adenomyosis.

Indexed as

AdenomyosisAdultCase-Control StudiesCaspase 3EndometriumFemaleHumansHypoxia-Inducible Factor 1, alpha SubunitIsocitrate DehydrogenaseMiddle AgedNeovascularization, PathologicProto-Oncogene Proteins c-bcl-2Retrospective StudiesVascular Endothelial Growth FactorsBCL2 protein, humanCASP3 protein, humanCaspase 3Hypoxia-Inducible Factor 1, alpha SubunitIDH1 protein, humanIsocitrate DehydrogenaseProto-Oncogene Proteins c-bcl-2Vascular Endothelial Growth FactorsAdenomyosisBcl-2HIF-1AIDH1VEGF

Identifiers

PMID32785780
OpenAlexW3048604449

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.